Table 4. Age-specific results from multiple logistic regression* to evaluate the effect of invasive strategy on in-hospital and long-term outcomes.
< 75 years | ≥ 75 years | Interaction† | |||||
OR | 95% CI | p value | OR | 95% CI | p value | p value | |
All-cause mortality | |||||||
In-hospital | 0.204 | 0.041-0.991 | 0.048 | 1.096 | 0.351-3.416 | 0.875 | 0.077 |
One-year | 0.168 | 0.061-0.463 | 0.001 | 0.429 | 0.188-0.977 | 0.044 | 0.201 |
Three-year | 0.323 | 0.150-0.695 | 0.004 | 0.267 | 0.123-0.578 | 0.001 | 0.81 |
MACE (death/MI/stroke) | |||||||
In-hospital | 0.212 | 0.056-0.800 | 0.022 | 1.049 | 0.361-3.046 | 0.93 | 0.072 |
One-year | 0.236 | 0.103-0.543 | 0.001 | 0.416 | 0.191-0.907 | 0.028 | 0.273 |
Three-year | 0.327 | 0.158-0.676 | 0.003 | 0.407 | 0.195-0.851 | 0.017 | 0.578 |
* Adjusted for age, sex, medical history (hypertension, diabetes mellitus, hypercholesterolemia, and current smoker), GRACE risk score, and medications (angiotensin-converting enzyme inhibitors, β-blockers, statins).
† Testing the interaction between age group and invasive treatment.